DUPLIZMO Trademark
DUPLIZMO is a USPTO trademark filed by Sanofi Biotechnology. Status: Cancelled.
Prosecution Summary
Trademark Summary
DUPLIZMO is a standard character mark covering anti-inflammatories and pharmaceutical products and preparations for the treatment of allergies and asthma in International Class 005, along with goods or services in domestic classes 006, 018, 044, 046, 051, and 052. The mark is owned by Sanofi Biotechnology, a French corporation based at 54, rue La Boétie, 75008 Paris, France. It reached registration but is now cancelled due to failure to file an acceptable Section 8 declaration, effective January 6, 2023, with no active classes remaining.
Recent Activity
The application was filed on October 30, 2015, published for opposition on April 5, 2016, and registered on the Principal Register on June 21, 2016. It was cancelled under Section 8
Trademark Facts
| Mark | DUPLIZMO |
|---|---|
| Serial Number | 86805285 |
| Registration Number | 4982975 |
| Status | Cancelled |
| Filing Date | 2015-10-30 |
| Registration Date | 2016-06-21 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Sanofi Biotechnology |
| Attorney of Record | Karen Lim |
| Prosecution Events | 18 |
| Latest Event | C8.. on 2023-01-06 |